Our results would predict that shifts in STAT1 splicing towards a predominant expression of Stat1β would considerably compromise NK cell-dependent tumor surveillance and that this defect cannot be overcome by treatment with exogenous IL-15/IL-15Rα. This evidence concerns the gene IL15 and neoplasm.